Hazlett, Burt & Watson’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10
Closed -$1K 912
2025
Q3
$1K Sell
10
-30
-75% -$2.31K ﹤0.01% 832
2025
Q2
$3K Buy
40
+10
+33% +$591 ﹤0.01% 694
2025
Q1
$2K Hold
30
﹤0.01% 711
2024
Q4
$3K Buy
+30
New +$2.99K ﹤0.01% 651
2024
Q3
Sell
-30
Closed -$3K 720
2024
Q2
$3K Sell
30
-28
-48% -$3.33K ﹤0.01% 620
2024
Q1
$8K Hold
58
﹤0.01% 531
2023
Q4
$8K Sell
58
-122
-68% -$16.8K 0.01% 509
2023
Q3
$30K Buy
180
+10
+6% +$1.99K 0.02% 366
2023
Q2
$38K Hold
170
0.03% 338
2023
Q1
$37K Buy
170
+10
+6% +$2.46K 0.03% 315
2022
Q4
$35K Hold
160
0.03% 315
2022
Q3
$42K Hold
160
0.04% 279
2022
Q2
$33K Hold
160
0.03% 313
2022
Q1
$35K Buy
+160
New +$33.8K 0.03% 323

Other funds holding ALB

Hazlett, Burt & Watson's ALB Position: Q4 2025 in Review

Hazlett, Burt & Watson sold out of Albemarle (ALB) in Q4 2025, closing a stake of 10 shares — an estimated $1K sold.

Hazlett, Burt & Watson first reported a position in ALB in Q1 2022 and held it in 14 quarters. The position peaked at $42K in Q3 2022. 909 funds tracked by Wall St. Rank hold ALB as of Q4 2025.

  • Hazlett, Burt & Watson reported no remaining Albemarle position as of Q4 2025 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 10 Albemarle shares in Q4 2025, an estimated $1K.
  • Hazlett, Burt & Watson first reported a position in Albemarle in Q1 2022 and held it in 14 quarters.
  • Hazlett, Burt & Watson's Albemarle position peaked at $42K in Q3 2022.
  • 909 funds tracked by Wall St. Rank held Albemarle as of Q4 2025.

Based on Hazlett, Burt & Watson's 13F filing for Q4 2025, filed 10 Feb 2026.